IRIS
CLEMENTI, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 555
NA - Nord America 510
AS - Asia 75
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
AF - Africa 1
SA - Sud America 1
Totale 1.150
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 508
SE - Svezia 346
IT - Italia 135
CN - Cina 47
FI - Finlandia 28
IE - Irlanda 16
DE - Germania 14
SG - Singapore 9
SA - Arabia Saudita 6
IN - India 5
RU - Federazione Russa 5
AU - Australia 4
RO - Romania 4
IR - Iran 3
A1 - Anonimo 2
CA - Canada 2
CH - Svizzera 2
EU - Europa 2
HK - Hong Kong 2
PL - Polonia 2
BR - Brasile 1
FR - Francia 1
GB - Regno Unito 1
KR - Corea 1
NL - Olanda 1
PH - Filippine 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 1.150
Salva come PNG Salva come JPEG
Città #
Ashburn 105
Milan 85
Princeton 81
Lawrence 78
New York 64
Shanghai 38
Helsinki 28
Dublin 16
Washington 9
Los Angeles 8
Rome 8
Seattle 6
Jeddah 5
Pune 5
Ancona 4
Turin 4
Bologna 3
Busto Arsizio 3
Frankfurt Am Main 3
Lansing 3
Melbourne 3
Riccione 3
Santa Clara 3
Ascoli Piceno 2
Como 2
Gatchina 2
Kunming 2
Las Vegas 2
Singapore 2
Tongling 2
Varese 2
Zurich 2
Andover 1
Bacoor 1
Bari 1
Beijing 1
Bergamo 1
Bloemfontein 1
Borås 1
Central 1
Charlottesville 1
Dresano 1
Frankfurt am Main 1
Guangzhou 1
Hamilton 1
Houston 1
Karachi 1
Kwai Chung 1
London 1
Napoli 1
Omsk 1
Palaia 1
Riverside 1
Riyadh 1
Rockville 1
San Diego 1
Segrate 1
Shenzhen 1
St Petersburg 1
Sydney 1
São Paulo 1
Tehran 1
Volgograd 1
Yazd 1
Totale 615
Salva come PNG Salva come JPEG
Nome #
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 35
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 30
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 29
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 27
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines 25
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 25
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 23
A Biologically-validated HCV E1E2 Heterodimer Structural Model 23
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 22
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 21
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 21
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 20
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 19
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 19
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 19
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 19
Answer to Photo Quiz: Scolecobasidium sp 19
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 18
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 18
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 18
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 18
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 18
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 17
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 17
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 17
Viral Respiratory Pathogens and Lung Injury 17
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 17
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 17
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 16
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 16
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review 16
The interferon landscape along the respiratory tract impacts the severity of COVID-19 16
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 15
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 15
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 15
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 15
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 15
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 15
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 14
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 14
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 14
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 14
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 14
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 14
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 14
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 13
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 13
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 13
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 13
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 13
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 13
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 13
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 13
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 12
HCV E2 core structures and mAbs: something is still missing 12
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 12
Role and potential therapeutic use of antibodies against herpetic infections 12
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 12
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 12
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples 12
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 11
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 11
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing 11
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 10
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 10
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 10
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 10
Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection 10
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 9
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 9
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 9
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 9
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 9
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 9
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia 9
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 9
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 9
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 8
Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic 8
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 7
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 7
Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021 7
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening 7
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes 7
Title: Acute respiratory distress in a neutropenic febrile patient after Hematopoietic Cell Transplantation 7
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies 7
Type III interferons disrupt the lung epithelial barrier upon viral recognition 7
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy 6
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 6
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 6
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV) 6
Potential impact of a microarray-based nucleic acid assay for rapid detection of gram-negative bacteria and resistance markers in positive blood cultures 6
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital 6
Rational Dosing Strategies of Colistin: What About Resistance? 5
Human Monoclonal Antibody able to nneutralize a broad range of H1 and H3 subtype influenza A viruses 5
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules 4
Beauveria bassiana Keratitis: A Case Series and Review of Literature 4
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota 4
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases? 4
Molecular Cloning of a Human Monoclonal Antibody neutralizing a broad range of H1 subtype influenza virus including swine-origin influenza virus (S-OIV) 4
Totale 1.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.947
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 11 0 0 0 0 0 9 0 0 0 0 3
2020/202128 5 1 0 3 6 0 3 4 0 6 0 0
2021/2022115 3 7 13 18 12 7 12 6 3 10 6 18
2022/2023643 191 151 74 8 7 82 43 45 24 2 11 5
2023/2024461 17 31 78 72 45 120 23 48 6 19 2 0
Totale 1.349